维普期刊资源整合服务平台（V6.5）

153篇 您的检索式：作者名="OLIVIERI D"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions显示文摘Pancreatic cancer(PDAC) is an aggressive and chemoresistant disease, representing the fourth cause of cancer related deaths in western countries. Majority of patients have unresectable, locally advanced or metastatic disease at time of diagnosis and the 5-year survival rate in these conditions is extremely low. For more than a decade gemcitabine has been the cornerstone of metastatic PDAC treatment, although survival benefit was very poor. PDAC cells are surrounded by an intense desmoplastic reaction that may create a barrier to the drugs penetration within the tumor. Recently PDAC stroma has been addressed as a potential therapeutic target. Nano albumin bound(Nab)-paclitaxel is an innovative molecule depleting tumor stroma, through interaction between albumin and secreted protein acidic and rich in cysteine. Addition of nab-paclitaxel to gemcitabine has showed activity and efficacy in metastatic PDAC first-line treatment improving survival and overall response rate vs gemcitabine alone in the MPACT phase Ⅲ study. This combination represents one of the standards of care in advanced PDAC therapy and is suitable to a broader spectrum of patients compared to other schedules. Nab-paclitaxel is under investigation as a backbone of chemotherapy in novel combinations with target agents or immunotherapy in locally advanced or metastatic PDAC. In this article, we provide an updated and critical overview about the role of nab-paclitaxel in PDAC treatment based on the latest advances in preclinical and clinical research. Furthermore, we focus on the use of nab-paclitaxel within the context of metastatic PDAC treatment landscape and we discuss about future implications in the light of current clinical ongoing trials.	Guido Giordano Massimo Pancione Nunzio Olivieri Pietro Parcesepe Marianna Velocci Tania Di Raimo Luigi Coppola Giuseppe Toffoli Mario Rosario D’Andrea	2017	World Journal of Gastroenterology2017，23，32：	7
2	Interaction between smoking and PON2 Ser311Cys polmorphism as a determinant of the risk of myocardial infaretion显示文摘	Matinelli M Girelli D Olivieri O	2004	Eur J Clin Invest2004，34，1：	1
3	Circulating inflamma-miRs in aging and age-related diseases显示文摘	Olivieri F Rippo M R Procopio A D	2013	Front Genet2013，4，：	1
4	Aldosterone to renin ratio in a primary care setting:the Bussolengo study显示文摘	Olivieri O Ciaeciarelli A Signorelli D	2004	J Clin Endoctinol Metab2004，89，9：	1
5	The airway neurogenic inflammation:clinical and pharmacological implications显示文摘	Pisi G Olivieri D Chetta A	2009	Inflamm Allergy Drug Targets2009，8，3：	1
6	Oxidative stress in the pathogenesis of diffuse lung diseases:A review显示文摘	Bargagli E Olivieri C Bennett D	2009	Respir Med2009，103，9：	1
7	1D graphene-like silicon systems:silicene nano-ribbons显示文摘	Padova P D Perfetti P Olivieri B	2012	J Phys:Condens Matter2012，24，22：	1
8	An in vivo RNAi assay identifies major genetic and cellular requirements for primarypiRNA biogenesis in Drosophila显示文摘	OLIVIERI D SYKORA M M SACHIDANANDAM R	2010	EMBOJ2010，29，19：	1
9	Successful treatment of recalcitrant genital ulcers of Behcet's disease with adalimumab after fail- ure of infliximab and elanereept 显示文摘	Olivieri I D'Angelo S Padula A	2009	Clin Exp Rheumatol2009，27，2153：	1
10	Late-onset rheumatoid arthritis and late-onset spondyloarthritis 显示文摘	Olivieri I Pipitone N D'Angelo S	2009	Cliu Exp Rheumatol2009，27，4：	1
11	Air particulate matter and cardiovascular disease : a narrative review 显示文摘	MARTINELLI N OLIVIERI O GIRELLI D	2013	Eur J Intern Med2013，24，：	1
12	Effect of short-term treatment with low-dose in-haled flutieasone propionate on airway inflammation and remode-ling in mild asthma: a placebo-controlled study显示文摘	Olivieri D Chetta A Del Donno M BertoreLli G Casalini A Pesci A	1997	Am J Respir Crit Care Med1997，155，6：	1
13	显示文摘	D' Ippolito R Chetta A	2000	Curr Opin Pulm Med2000，6，5：	1
14	Diagnostic invasive procedures in diffuse infiltrative lung diseases显示文摘	Poletti V Chilosi M Olivieri D	2004	Respiration2004，71，：	1
15	Oxidative stress in thepathogenesis of diffuse lung diseases: a review 显示文摘	Bargaglie E Olivieri C Bennett D	2009	Respir Med2009，103，9：	1
16	Anti-oxidant status and lipid peroxidation in patients with essential hypertension显示文摘	Russo C Olivieri O Girelli D	1998	J Hypertens1998，16，：	1
17	Air particulate matter and cardiovascular disease: a narrative review显示文摘	Martinelli N Olivieri O Girelli D	2013	Eur J Intern Med2013，24，：	1
18	Interest of Chro- mogranin A for diagnosis and follow-up of endocrine tumours 显示文摘	Nehar D Lombard-Bohas C Olivieri S	2004	Clin Endocrinol (Oxf)2004，60，5：	1
19	Estimation of pathogen removal in an advanced water treatment facility using Monto Carlo simulation显示文摘	Olivieri A Eisenberg D SoUer J etal	1999	Water Science and Technology1999，40，45：	1
20	Aldosterone to renin ratio in a primary care setting:the Bussolengo study 显示文摘	Olivieri O Ciacciarelli A Signorelli D	2004	J Clin Endocrinol Metab2004，89，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示